+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Seizure Drug"

Partial Seizure - Pipeline Insight, 2025 - Product Thumbnail Image

Partial Seizure - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Seizures - Pipeline Insight, 2025 - Product Thumbnail Image

Seizures - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Seizures Pipeline Insight Analysis Report - Product Thumbnail Image

Seizures Pipeline Insight Analysis Report

  • Drug Pipelines
  • August 2024
  • 150 Pages
  • Global
From
Peripheral Neuropathy Market Report 2025 - Product Thumbnail Image

Peripheral Neuropathy Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Epilepsy Drugs Market Report 2025 - Product Thumbnail Image

Epilepsy Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Anticonvulsants Market Report 2025 - Product Thumbnail Image

Anticonvulsants Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Epilepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Epilepsy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 280 Pages
  • Global
From
Tuberous Sclerosis- Pipeline Insight, 2025 - Product Thumbnail Image

Tuberous Sclerosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ionotropic Glutamate Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Ionotropic Glutamate Receptor Antagonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
From
Chemotherapy Induced Peripheral Neuropathy- Pipeline Insight, 2025 - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Refractory Epilepsy - Pipeline Insight, 2025 - Product Thumbnail Image

Refractory Epilepsy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
Loading Indicator

The Seizure Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Seizure Drugs are used to treat epilepsy, a neurological disorder characterized by recurrent seizures. These drugs work by reducing the frequency and severity of seizures, and can be administered orally, intravenously, or rectally. Commonly used Seizure Drugs include anticonvulsants, benzodiazepines, and barbiturates. Seizure Drugs are typically prescribed by neurologists and other healthcare professionals. The market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the Seizure Drug market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more